Development of diabetic cardiomyopathy and the kallikrein-kinin system--new insights from B1 and B2 receptor signaling.
Diabetic cardiomyopathy is a specific cardiomyopathy which develops in patients with diabetes mellitus in the absence of coronary atherosclerosis and hypertension. Despite the potential importance of this disease entity, the underlying mechanisms are only incompletely understood. Changes in calcium handling, disruption of the extracellular matrix regulation with accumulation of cardiac collagen, and furthermore cardiac inflammation may be an important mediator of this disease. This brief review focuses on the current aspects of the kallikrein-kinin system and its influence on the development of diabetic cardiomyopathy with particular regard to the kinin receptors B1 and B2, as their role in the development of this disease is still under discussion. Whether the role of the B1 receptor is similar to the well-described beneficial role of the B2 receptor or whether its function is opposed to the B2 receptor is controversial. Some recent findings suggest that the B1 receptor mediates cardiac inflammation and therefore may be detrimental for cardiac function in the setting of diabetic cardiomyopathy.
Tschöpe
Carsten
C
Department of Cardiology and Pneumology, Charité-University Medicine Berlin, Campus Benjamin Franklin, D-12200 Berlin, Germany. carsten.tschoepe@charite.de
Westermann
Dirk
D
D000818:Animals; D009202:Cardiomyopathies / Q000150:complications / Q000201:enzymology / Q000378:metabolism*; D048909:Diabetes Complications / Q000150:complications / Q000201:enzymology / Q000378:metabolism*; D006801:Humans; D007610:Kallikreins / Q000378:metabolism*; D007705:Kinins / Q000378:metabolism*; D018002:Receptors, Bradykinin / Q000378:metabolism*; D015398:Signal Transduction
D007705:Kinins; D018002:Receptors, Bradykinin; D007610:Kallikreins